Mufg Securities Americas Inc. bought a new stake in Danaher Co. (NYSE:DHR – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 9,489 shares of the conglomerate’s stock, valued at approximately $2,178,000.
Several other hedge funds also recently modified their holdings of the stock. Malaga Cove Capital LLC raised its position in Danaher by 23.5% in the 4th quarter. Malaga Cove Capital LLC now owns 5,298 shares of the conglomerate’s stock valued at $1,216,000 after buying an additional 1,007 shares during the last quarter. NorthRock Partners LLC raised its holdings in shares of Danaher by 129.7% in the fourth quarter. NorthRock Partners LLC now owns 8,323 shares of the conglomerate’s stock valued at $1,910,000 after purchasing an additional 4,700 shares during the last quarter. Nuveen Asset Management LLC raised its holdings in shares of Danaher by 2.8% in the fourth quarter. Nuveen Asset Management LLC now owns 4,068,948 shares of the conglomerate’s stock valued at $934,027,000 after purchasing an additional 111,894 shares during the last quarter. Numerai GP LLC bought a new position in shares of Danaher during the fourth quarter valued at about $1,983,000. Finally, OMERS ADMINISTRATION Corp grew its position in Danaher by 74.3% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 50,202 shares of the conglomerate’s stock worth $11,524,000 after purchasing an additional 21,397 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on the stock. Jefferies Financial Group decreased their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Raymond James restated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. StockNews.com upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Monday. Finally, Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research report on Friday, March 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.
Insider Activity
In other news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.10% of the company’s stock.
Danaher Stock Performance
Shares of DHR stock opened at $196.60 on Wednesday. The firm’s 50 day moving average is $197.83 and its 200 day moving average is $218.54. The stock has a market capitalization of $140.70 billion, a P/E ratio of 37.23, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher’s payout ratio is presently 24.85%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- What is the Euro STOXX 50 Index?
- U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 AI ETFs Tapping Into the Heart of the AI Revolution
- What is the S&P 500 and How It is Distinct from Other Indexes
- Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.